Ozdamar Sukru O, Gucer Safak, Tinaztepe Keriman
Department of Pathology, Hacettepe University School of Medicine, Ankara, Turkey.
Pediatr Nephrol. 2003 Jan;18(1):23-8. doi: 10.1007/s00467-002-0978-z. Epub 2002 Nov 22.
Hepatitis B virus (HBV)-associated glomerulonephritides have been increasingly reported, and the association between HBV and glomerulopathy is striking, especially in children. In this study, we investigated clinical and immunohistological features of HBV-associated glomerulonephritis in 14 children aged from 2.5 to 16 years (mean 10 years). The nephrotic syndrome was present in 9 (64%) and the nephritic syndrome in 8 children (57%). Five children had both nephrotic and nephritic syndrome together (35%). Renal insufficiency was determined in 4 of 14 patients (28%). Surface antigen (HBsAg) was present in all, with no history of clinically apparent hepatitis. Investigation of all renal tissue samples with light and immunofluorescence microscopy confirmed the diagnosis of membranous glomerulonephritis (MGN) in 6, membranoproliferative glomerulonephritis (MPGN) in 7, and IgA nephropathy (IgAN) in 1 child. Renal tissue samples were studied by the immunoperoxidase method for HBsAg in all cases; only in 4 children was HBsAg detected in the glomeruli. Examination of liver tissue samples was available in 4 cases, revealing chronic hepatitis in all, with additional development of cirrhosis in 1 and the presence of HBsAg in hepatocytes in all. Of the patients, 8 received corticosteroid treatment; 1 of them achieved a complete remission, while 4 had a partial remission with persistent proteinuria and hematuria. Four patients who received no treatment had a spontaneous remission within 5 months to 10 years following the onset of the renal disease. Two patients died of renal failure, while 1 died of intercurrent sepsis. The patient with IgAN received interferon-alpha 2a and lamuvidine, which resulted in a remission and a marked decrease in HBV DNA titer. The remaining 2 were lost to follow-up. Although MGN has been reported as the nephropathy most commonly associated with HBsAg antigenemia in adults, our study revealed that MPGN could occur in children as well as MGN, without any clinical or historical evidence of hepatitis. The present study provides further evidence for a causal relationship between HBV hepatitis and HBs antigenemia-related glomerulonephritides in the pediatric age group. It also indicates the prognosis (71%) of the associated nephropathies with or without treatment is quite favorable in childhood.
乙型肝炎病毒(HBV)相关性肾小球肾炎的报道日益增多,HBV与肾小球病之间的关联十分显著,在儿童中尤为如此。在本研究中,我们调查了14名年龄在2.5至16岁(平均10岁)的儿童HBV相关性肾小球肾炎的临床和免疫组织学特征。9名儿童(64%)出现肾病综合征,8名儿童(57%)出现肾炎综合征。5名儿童同时患有肾病综合征和肾炎综合征(35%)。14名患者中有4名(28%)存在肾功能不全。所有患者均存在表面抗原(HBsAg),且无明显肝炎病史。对所有肾组织样本进行光镜和免疫荧光显微镜检查,确诊6例为膜性肾小球肾炎(MGN),7例为膜增生性肾小球肾炎(MPGN),1例为IgA肾病(IgAN)。所有病例均采用免疫过氧化物酶法检测肾组织样本中的HBsAg;仅4名儿童的肾小球中检测到HBsAg。4例患者有肝组织样本可供检查,均显示为慢性肝炎,其中1例并发肝硬化,所有肝细胞中均存在HBsAg。8例患者接受了皮质类固醇治疗;其中1例完全缓解,4例部分缓解,但仍有持续性蛋白尿和血尿。4例未接受治疗的患者在肾病发病后5个月至10年内自发缓解。2例患者死于肾衰竭,1例死于并发败血症。IgAN患者接受了α-2a干扰素和拉米夫定治疗,病情缓解,HBV DNA滴度显著下降。其余2例失访。尽管MGN被报道为成人中最常与HBsAg抗原血症相关的肾病,但我们的研究表明,MPGN在儿童中也可能发生,与MGN一样,且无任何肝炎的临床或病史证据。本研究进一步证明了HBV肝炎与小儿年龄组中HBs抗原血症相关肾小球肾炎之间的因果关系。它还表明,无论是否接受治疗,相关肾病在儿童期的预后(71%)相当良好。